China Signals Openness to Deal That Could Keep TikTok Operating in the US Micron Stock Hits Milestone as UBS Sets Ambitious Price Target on Strong Memory Chip Demand Memory Takes Center Stage in AI Race Says Sandisk CTO Nansledan Development in Cornwall CommunityFocused Retail Model May Reshape Local High Street Dynamics Bitcoin Slips Below 76000 as Renewed Iran Tensions and ETF Outflows Weigh on Market Iran Never Bow Vow and Trump Counteroffer Rejection Intensify Middle East Tensions Raising Oil Supply Risks Capital Bancorp Inc CBNK Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Decline GRCE Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Rally APEI Q1 2026 Earnings EPS Soars Past Estimates Stock Dips Slightly GSHD Q1 2026 Earnings EPS Smashes Estimates by 794 Amid Strong Operational Execution OCCIO Q1 2026 Earnings Preferred Stock Reports Negative EPS of 076 Sharply Missing Estimates Union Bankshares Inc UNB Q2 2025 Earnings Shares Gain on Reported EPS of 053 Mohawk Industries Holds Steady Near Key Resistance as Flooring Sector Navigates Demand Uncertainty Apollomics Inc Warrant APLMW Holds Steady Near Minimal Levels A Closer Look at the Biotech Derivative Innospec Inc IOSP Holds Steady Near 82 Amid Low Volatility NeoVolta Warrants NEOVW Hold Steady at 122 as Key Levels Tighten GATX Corporation Slips 188 as Railcar Leasing Stock Tests Key Support Levels CRSR Q1 2026 Earnings Strong Earnings Beat Drives DoubleDigit Share Price Rally Bright Horizons BFAM Q1 2026 Earnings EPS Beats Estimates by a Slim Margin as Stock Edges Lower AGRO Q1 2026 Earnings Significant EPS Miss Amid Challenging Agricultural Conditions Arlo Technologies Q1 2026 Earnings EPS Surges Past Estimates Stock Gains as Profitability Improves Immunome Inc IMNM Q1 2026 Earnings Narrower Loss Beats Estimates Stock Gains Modestly MSCI Q1 2026 Earnings Slight EPS Beat Supports Positive Market Response How TikToks Discovery Engine Is Reshaping Creator and Brand Revenue Streams UZD Q1 2026 Earnings Significant EPS Beat Drives Stock Uptick Neumora Therapeutics NMRA Holds Steady at 185 Amid Mixed Sentiment